DISEASE SCANNER
Global Incurable Diseases Tracker
Focal Segmental Glomerulosclerosis (FSGS)
A rare kidney disorder characterized by scarring (sclerosis) in scattered regions (focal) of the kidney's glomeruli (segmental). It is a leading cause of nephrotic syndrome and end-stage renal disease. Can be primary (idiopathic) or secondary to various conditions including genetic mutations, infections, or drug toxicity.
540.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Urinalysis (proteinuria)
- 2Blood tests (albumin, lipids)
- 3Kidney biopsy (gold standard)
- 4Genetic testing
- 5Renal ultrasound
- 624-hour urine protein
Prognosis
Variable; primary FSGS has 50-70% progression to ESRD within 10 years without treatment. Response to steroids improves prognosis. Recurrence common after transplant (20-50%).
Prevention
- Blood pressure control
- Weight management
- Avoid nephrotoxic drugs
- Genetic counseling for familial forms
Research Status
Immunosuppressive therapy with corticosteroids, calcineurin inhibitors. ACE inhibitors/ARBs for proteinuria control. Plasma exchange for recurrent FSGS post-transplant. Novel therapies targeting APOL1 variants in development.
Affected Countries
Sources
- https://www.kidney.org/atoz/content/focal-segmental-glomerulosclerosis
- https://www.ncbi.nlm.nih.gov/books/NBK507702
- https://www.niddk.nih.gov/health-information/kidney-disease/focal-segmental-glomerulosclerosis
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.